Harvard, Tufts med students stage protest at ‘biased’ $2.9B drug development figure

Ben Adams Around two dozen students from Harvard Medical School and Tufts University as well as members of health activist groups protested in front of the Tufts Center for the Study ...

Say what? CVS Health execs figure PCSK9 meds to cost up to $150B

Tracy Staton CVS Health is raising eyebrows with a new estimate: A coming class of pricey cholesterol meds could cost the U.S. as much as $ 150 billion per year. FiercePharma ...

Celltrion’s manufacturing ops figure in AstraZeneca buyout buzz

John Carroll Rumors are swirling that AstraZeneca may have its sights set on the Korean biosimilars maker, and a buyout would give the British drugmaker–or any of its rivals–an ...

The pharma spin-offs have just begun, bankers figure

Tracy Staton Want to see more divestment action in Big Pharma? Just wait. That's what investment bankers are predicting, now that Pfizer and AbbVie have led the way. FiercePharma ...

Who Will Figure Out How to Make a Business Out of Fecal Transplants?

Alok Saboo By Bernat Olle, PureTech Ventures Does it have to be a biotech or pharma company that figures out a way to monetize fecal transplants (FTs)? Or will hospitals find a way ...
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS